Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized tial with palliative end points

D. J. Bloomfield, M. D. Krahn, T. Neogi, T. Panzarella, T. J. Smith, P. Warde, A. R. Willan, S. Ernst, M. J. Moore, A. Neville, I. F. Tannock

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized tial with palliative end points'. Together they form a unique fingerprint.

Medicine & Life Sciences